AI Program Lead

About the Position

AI Program Lead

Remote (UTC +/- 2 hrs)

Full-time

Permanent employee

About Apheris

Apheris hosts the industry's largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability. Leading pharma companies train higher-performing models on this data without ever exposing it, and we deliver those models through Apheris Foundry, our drug discovery platform.

About the Role

We're building out the team that turns our networks into models pharma teams actually use. You'll scope and stand up new networks, run execution end to end with partners like the world's top pharma companies, and get Apheris Foundry embedded into their live drug discovery programs, not just evaluated, actually used. This is a high-ownership, high-visibility seat. You'll be the person top pharma scientists call when something needs to move, and the person who turns a network from concept to models running in production. Our networks are scaling fast and the work is only getting bigger from here.

Responsibilities

• Scope and stand up new networks
• Run execution end to end with top pharma companies
• Embed Apheris Foundry into live drug discovery programs

Requirements

• 3+ years in scientific or technical program management, alliance management, or customer-facing delivery of scientific software
• Knowledge of molecular ML and drug discovery workflows
• Experience in managing complex, multi-party programs
• Ability to manage a process and own an outcome

We Offer

• Competitive compensation with early-stage virtual share options
• Remote-first setup with real flexibility on where you work
• Genuine investment in your wellbeing: mental health support, a work-from-home and co-working budget, a learning budget, and generous holiday
• Team gatherings three times a year in Berlin and elsewhere in Europe

About the Company

Apheris hosts the industry's largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability. Leading pharma companies train higher-performing models on this data without ever exposing it, and we deliver those models through Apheris Foundry, our drug discovery platform.